Role of PINCH and Its Partner Tumor Suppressor Rsu-1 in Regulating Liver Size and Tumorigenesis

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Donthamsetty, Shashikiran ^a   Bhave, Vishakha S ^b   Mars, Wendy M ^a   Bowen, William C ^a   Orr, Anne ^a   Haynes, Meagan M ^a   Wu, Chuanyue ^a   Michalopoulos, George K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; INTEGRIN; PARTICULARLY INTERESTING NEW CYSTEINE HISTIDINE RICH PROTEIN; RAS SUPPRESSOR 1 PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; HEPATOMA CELL; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; LIVER REGENERATION; LIVER SIZE; MOUSE; NONHUMAN; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; BODY WEIGHT; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DOWN-REGULATION; EXTRACELLULAR MATRIX; HEPATOCYTES; HUMANS; KINETICS; LIM DOMAIN PROTEINS; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; ORGAN SIZE; RATS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84884221288     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074625     Document Type: Article

References (38)

1. Francavilla A, Ove P, Polimeno L, Coetzee M, Makowka L, et al. (1988) Regulation of liver size and regeneration: importance in liver transplantation. Transplant Proc 20: 494-497. PubMed: 3279642.
2. Kam I, Lynch S, Svanas G, Todo S, Polimeno L, et al. (1987) Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology 7: 362-366. doi:10.1002/hep.1840070225. PubMed: 3549508.
3. Starzl TE, Fung J, Tzakis A, Todo S, Demetris AJ, et al. (1993) Baboon-to-human liver transplantation. Lancet 341: 65-71. doi:10.1016/0140-6736(93)92553-6. PubMed: 8093402.
4. Gkretsi V, Apte U, Mars WM, Bowen WC, Luo JH, et al. (2008) Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegaly. Hepatology 48: 1932-1941. doi:10.1002/hep.22537. PubMed: 18846549.
5. Gkretsi V, Mars WM, Bowen WC, Barua L, Yang Y, et al. (2007) Loss of integrin linked kinase from mouse hepatocytes in vitro and in vivo results in apoptosis and hepatitis. Hepatology 45: 1025-1034. doi:10.1002/hep.21540. PubMed: 17385211.
6. Apte U, Gkretsi V, Bowen WC, Mars WM, Luo JH, et al. (2009) Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology 50: 844-851. doi:10.1002/hep.23059. PubMed: 19575460.
7. Kovalevich J, Tracy B, Langford D, (2011) PINCH: More than just an adaptor protein in cellular response. J Cell Physiol 226: 940-947. doi:10.1002/jcp.22437. PubMed: 20945343.
8. Zhang Y, Chen K, Guo L, Wu C, (2002) Characterization of PINCH-2, a new focal adhesion protein that regulates the PINCH-1-ILK interaction, cell spreading, and migration. J Biol Chem 277: 38328-38338. doi:10.1074/jbc.M205576200. PubMed: 12167643.
9. Li S, Bordoy R, Stanchi F, Moser M, Braun A, et al. (2005) PINCH1 regulates cell-matrix and cell-cell adhesions, cell polarity and cell survival during the peri-implantation stage. J Cell Sci 118: 2913-2921. doi:10.1242/jcs.02422. PubMed: 15976450.
10. Stanchi F, Bordoy R, Kudlacek O, Braun A, Pfeifer A, et al. (2005) Consequences of loss of PINCH2 expression in mice. J Cell Sci 118: 5899-5910. doi:10.1242/jcs.02686. PubMed: 16317048.
11. Dougherty GW, Chopp T, Qi SM, Cutler ML, (2005) The Ras suppressor Rsu-1 binds to the LIM 5 domain of the adaptor protein PINCH1 and participates in adhesion-related functions. Exp Cell Res 306: 168-179. doi:10.1016/j.yexcr.2005.01.025. PubMed: 15878342.
12. Dougherty GW, Jose C, Gimona M, Cutler ML, (2008) The Rsu-1-PINCH1-ILK complex is regulated by Ras activation in tumor cells. Eur J Cell Biol 87: 721-734. doi:10.1016/j.ejcb.2008.02.011. PubMed: 18436335.
13. Nalesnik MA, Tseng G, Ding Y, Xiang GS, Zheng ZL, et al. (2012) Gene deletions and amplifications in human hepatocellular carcinomas: correlation with hepatocyte growth regulation. Am J Pathol 180: 1495-1508. doi:10.1016/j.ajpath.2011.12.021. PubMed: 22326833.
14. Liang X, Sun Y, Ye M, Scimia MC, Cheng H, et al. (2009) Targeted ablation of PINCH1 and PINCH2 from murine myocardium results in dilated cardiomyopathy and early postnatal lethality. Circulation 120: 568-576. doi:10.1161/CIRCULATIONAHA.109.864686. PubMed: 19652092.
15. Michalopoulos GK, (2007) Liver regeneration. J Cell Physiol 213: 286-300. doi:10.1002/jcp.21172. PubMed: 17559071.
16. Cutler ML, Bassin RH, Zanoni L, Talbot N, (1992) Isolation of rsp-1, a novel cDNA capable of suppressing v-Ras transformation. Mol Cell Biol 12: 3750-3756. PubMed: 1508180.
17. Vasaturo F, Dougherty GW, Cutler ML, (2000) Ectopic expression of Rsu-1 results in elevation of p21CIP and inhibits anchorage-independent growth of MCF7 breast cancer cells. Breast Cancer Res Treat 61: 69-78. doi:10.1023/A:1006462323260. PubMed: 10930091.
18. David M, Petit D, Bertoglio J, (2012) Cell cycle regulation of Rho signaling pathways. Cell Cycle 11: 3003-3010. doi:10.4161/cc.21088. PubMed: 22825247.
19. Morgan-Fisher M, Wewer UM, Yoneda A, (2013) Regulation of ROCK Activity in Cancer. J Histochem Cytochem, 61: 185-98. PubMed: 23204112.
20. Street CA, Bryan BA, (2011) Rho kinase proteins--pleiotropic modulators of cell survival and apoptosis. Anticancer Res 31: 3645-3657. PubMed: 22110183.
21. Etienne-Manneville S, Hall A, (2002) Rho GTPases in cell biology. Nature 420: 629-635. doi:10.1038/nature01148. PubMed: 12478284.
22. Boudreau NJ, Jones PL, (1999) Extracellular matrix and integrin signalling: the shape of things to come. Biochem J 339(Pt 3): 481-488 doi:10.1042/0264-6021:3390481. PubMed: 10215583.
23. Hehlgans S, Haase M, Cordes N, (2007) Signalling via integrins: implications for cell survival and anticancer strategies. Biochim Biophys Acta 1775: 163-180. PubMed: 17084981.
24. Block GD, Locker J, Bowen WC, Petersen BE, Katyal S, et al. (1996) Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium. J Cell Biol 132: 1133-1149. doi:10.1083/jcb.132.6.1133. PubMed: 8601590.
25. Michalopoulos GK, Bowen WC, Zajac VF, Beer-Stolz D, Watkins S, et al. (1999) Morphogenetic events in mixed cultures of rat hepatocytes and nonparenchymal cells maintained in biological matrices in the presence of hepatocyte growth factor and epidermal growth factor. Hepatology 29: 90-100. doi:10.1002/hep.510290149. PubMed: 9862855.
26. Duncan AW, (2013) Aneuploidy, polyploidy and ploidy reversal in the liver. Semin Cell Dev Biol, 24: 347-56. PubMed: 23333793.
27. Saito JM, Maher JJ, (2000) Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. Gastroenterology 118: 1157-1168. doi:10.1016/S0016-5085(00)80446-1. PubMed: 10833491.
28. Wakabayashi Y, Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, et al. (2008) Mechanism of neutrophil accumulation in sinusoids after extrahepatic biliary obstruction. Hepatogastroenterology 55: 1179-1183. PubMed: 18795653.
29. Kossmann T, Manthey CL, Brandes ME, Morganti-Kossmann MC, Ohura K, et al. (1992) Kupffer cells express type I TGF-beta receptors, migrate to TGF-beta and participate in streptococcal cell wall induced hepatic granuloma formation. Growth Factors 7: 73-83. doi:10.3109/08977199209023939. PubMed: 1323980.
30. Xidakis C, Ljumovic D, Manousou P, Notas G, Valatas V, et al. (2005) Production of pro- and anti-fibrotic agents by rat Kupffer cells; the effect of octreotide. Dig Dis Sci 50: 935-941. doi:10.1007/s10620-005-2668-8. PubMed: 15906772.
31. Stolz DB, Michalopoulos GK, (1997) Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-beta 1 in vitro. J Cell Physiol 170: 57-68. doi:10.1002/(SICI)1097-4652(199701)170:1. PubMed: 9012785.
32. Tsuda T, Marinetti MR, Masuelli L, Cutler ML, (1995) The Ras suppressor RSU-1 localizes to 10p13 and its expression in the U251 glioblastoma cell line correlates with a decrease in growth rate and tumorigenic potential. Oncogene 11: 397-403. PubMed: 7624154.
33. Tsuda T, Cutler ML, (1993) Human RSU1 is highly homologous to mouse Rsu-1 and localizes to human chromosome 10. Genomics 18: 461-462. doi:10.1006/geno.1993.1503. PubMed: 8288261.
34. Bar-Sagi D, Hall A, (2000) Ras and Rho GTPases: a family reunion. Cell 103: 227-238. doi:10.1016/S0092-8674(00)00115-X. PubMed: 11057896.
35. Prendergast GC, Khosravi-Far R, Solski PA, Kurzawa H, Lebowitz PF, et al. (1995) Critical role of Rho in cell transformation by oncogenic Ras. Oncogene 10: 2289-2296. PubMed: 7784077.
36. Qiu RG, Chen J, McCormick F, Symons M, (1995) A role for Rho in Ras transformation. Proc Natl Acad Sci U S A 92: 11781-11785. doi:10.1073/pnas.92.25.11781. PubMed: 8524848.
37. Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, et al. (1996) Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol Cell Biol 16: 3923-3933. PubMed: 8668210.
38. Solaro RJ, (2000) Myosin light chain phosphatase: a Cinderella of cellular signaling. Circ Res 87: 173-175. doi:10.1161/01.RES.87.3.173. PubMed: 10926864.